Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This clinical study found that Rosmarinum officinalis mother tincture significantly improved hair volume and density in individuals with diffuse hair loss by enhancing hair parameters measured through a hair shedding visual scale and ponytail thickness test.

This study assessed the effects of the poly herbal formulation Hairbac, reporting significant improvements in hair texture, density, and loss among females with diffuse hair fall, with no adverse effects noted.

This study found that the TrichoScan software effectively differentiated between androgenetic alopecia and telogen effluvium in women with diffuse hair loss, aligning with clinical diagnoses.

This study found that a 6-week treatment with both brands of biotin and dexpanthenol significantly improved hair fall count and hair density in people with diffuse pattern hair loss, with no significant difference between the two brands.

In this article, the authors concluded that despite diverse causes of diffuse hair loss, modern therapies can effectively manage the condition without side effects, as demonstrated in two clinical cases of telogen effluvium.

This study found that among Japanese women with diffuse hair loss, decreased hair density without changes in vellus hair was the most common and distinct pattern observed, highlighting differences from previous observations in other populations.

This study found that sphinganine may improve scalp health, hair quality, and reduce hair loss in males, potentially due to increased antimicrobial peptide levels and inhibition of 5-α-reductase.

In this study, microneedling followed by topical 2% chitosan significantly improved hair growth parameters in patients with androgenetic alopecia, comparable to results with 5% minoxidil, but a small sample size limits definitive conclusions on their relative efficacy.

This study found that four months of oral nutrient supplements improved hair density by 16-21% and caliber by 18-22% in men and women with pollution-related hair loss, addressing oxidative damage without using finasteride, antiandrogens, or minoxidil.

Stem cell treatment improved hair density in female hair loss patient.

This article reviews the diagnosis and causes of different types of alopecia, presenting no new clinical findings.

This study suggests that seborrhoeic folliculitis may represent a unique form of cicatricial alopecia, linking chronic scalp dermatitis-folliculitis with low-grade inflammatory fibrosing alopecia.

This study found that hair care products containing fermented papaya, fermented mangosteen, and caffeine significantly inhibited hair loss, increased hair density and thickness, and improved hair follicle structure in individuals with androgenic or diffuse alopecia over three months compared to placebo and caffeine controls.

This publication describes the role of the Revista Brasileira de Cirurgia Plástica in documenting and promoting advancements in plastic surgery, but does not present new research findings.

This study reports that permanent and severe alopecia is a newly identified complication of the FEC 100–docetaxel regimen used for adjuvant breast cancer treatment.

This systematic review reports that acute telogen effluvium may occur as a stress-induced hair loss following COVID-19 recovery, with most patients experiencing hair regrowth over time.

This study concluded that TrichoScan is error-prone in its current form and overestimates certain hair growth parameters, with results not aligning with clinical severity of alopecia.

This study describes a clinical investigation of telogen effluvium with iron deficiency anemia, comparing treatment with Fe2+ salts alone to Fe2+ salts plus topical Qilib, but reports no new results.

This review summarizes expert opinions on the use of approved pharmacologic treatments alongside hair transplantation, highlighting their potential to enhance hair density and regrowth speed while reducing further hair loss, but reports no new clinical trial results.

This study observed that hair density and growth rates vary by location and age, and the presence of thin hairs predominates in younger women with mild patterned hair loss.

This article discusses androgenetic alopecia, its progression, signs of hyperandrogenism, and impacts on quality of life, without presenting new clinical findings.

This study observed that Japanese women experience diffuse central hair loss after age 40, characterized by reduced hair density and thicker hair ratio rather than vellus-like hairs.

This study reported that low-dose oral minoxidil combined with a 5α-reductase inhibitor improved hair density in most men with female pattern hair loss after 6 months or more of treatment.

This study found that a nutritional supplement containing millet extract, pantothenic acid, L-cystine, and biotin significantly increased hair density, improved hair growth and appearance, and reduced hair loss by 59% in 112 healthy subjects with light diffuse hair loss over 12 weeks.

This study found that women with androgenetic alopecia experience diffuse hair loss due to a decrease in terminal hairs and an increase in vellus hairs per follicular unit.

This case study highlights how trichoscopy helped differentiate between diffuse alopecia areata and trichotillomania in an 11-year-old girl, demonstrating its importance in distinguishing hair disorders with similar presentations.

This study concluded that high-dose oral therapy with L-cystine, gelatin, and vitamin A significantly improved hair growth indicators in patients with diffuse hair loss, with no systemic side effects observed.

Syphilis can cause hair loss without other symptoms and should be considered when diagnosing unexplained hair loss.

In this study, adenosine lotion significantly increased the proportion of thick hair among women with hair loss compared to placebo, showing potential as a safe and effective treatment without observed side effects.

This review discusses the causes, diagnosis, and treatment approaches for telogen effluvium but presents no new clinical findings; novel treatments like ALRV5XR are highlighted as promising.